Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Prediction of progression of diabetic retinopathy using automated lesion detection of retinal hemorrhages
Author Affiliations & Notes
  • Aditya Verma
    Doheny Eye Institute, Los Angeles, California, United States
    Department of Ophthalmology and Visual Sciences, University of Louisville, Louisville, Kentucky, United States
  • Muneeswar Gupta Nittala
    Doheny Eye Institute, Los Angeles, California, United States
  • Marius Facktor
    Eyenuk, Inc, California, United States
  • Chaithanya Ramachandra
    Eyenuk, Inc, California, United States
  • Malavika Bhaskaranand
    Eyenuk, Inc, California, United States
  • Sandeep Bhat
    Eyenuk, Inc, California, United States
  • Kaushal Solanki
    Eyenuk, Inc, California, United States
  • Chaitra jayadev
    Narayana Nethralaya, Bangalore, Karnataka, India
  • Swetha B. Velaga
    Doheny Eye Institute, Los Angeles, California, United States
  • SriniVas R Sadda
    Doheny Eye Institute, Los Angeles, California, United States
    University of California Los Angeles David Geffen School of Medicine, Los Angeles, California, United States
  • Footnotes
    Commercial Relationships   Aditya Verma None; Muneeswar Gupta Nittala None; Marius Facktor None; Chaithanya Ramachandra None; Malavika Bhaskaranand None; Sandeep Bhat None; Kaushal Solanki None; Chaitra jayadev None; Swetha B. Velaga None; SriniVas Sadda 4DMT, Abbvie, Alexion, Allergan Inc., Alnylam Pharmaceuticals, Amgen Inc., Apellis Pharmaceuticals, Inc., Astellas, Bayer Healthcare Pharmaceuticals, Biogen MA Inc., Boehringer Ingelheim, Carl Zeiss Meditec, Catalyst Pharmaceuticals Inc., Centervue Inc., GENENTECH, Gyroscope Therapeutics, Heidelberg Engineering, Hoffman La Roche, Ltd., Iveric Bio, Janssen Pharmaceuticals Inc., Nanoscope, Notal Vision Inc., Novartis Pharma AG, Optos Inc., Oxurion/Thrombogenics, Oyster Point Pharma, Regeneron Pharmaceuticals Inc., Samsung Bioepis, Topcon Medical Systems Inc., Code C (Consultant/Contractor), Carl Zeiss Meditec, Heidelberg Engineering, Optos Inc., Nidek, Topcon, Centervue, Code F (Financial Support), Carl Zeiss Meditec, Heidelberg Engineering, Nidek Incorporated, Novartis Pharma AG, Topcon Medical Systems Inc., Code R (Recipient)
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 3193. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Aditya Verma, Muneeswar Gupta Nittala, Marius Facktor, Chaithanya Ramachandra, Malavika Bhaskaranand, Sandeep Bhat, Kaushal Solanki, Chaitra jayadev, Swetha B. Velaga, SriniVas R Sadda; Prediction of progression of diabetic retinopathy using automated lesion detection of retinal hemorrhages. Invest. Ophthalmol. Vis. Sci. 2024;65(7):3193.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The extent of retinal hemorrhages, particular those located more peripherally, have been suggested to be an important predictor of progression to proliferative diabetic retinopathy (PDR). In this study, we evaluate whether automatically detected hemorrhages on ultra-wide field (UWF) pseudocolor images are predictive of DR progression over two years

Methods : Seventy-three patients (104 eyes) with various stages of DR were recruited from a tertiary care center in India, and UWF pseudocolor images were captured (Optos Daytona Plus). The “EyeReadUWF” algorithm (Eyenuk) was used to automatically detect retinal hemorrhages on stereographically projected images. The resultant annotation “masks”/layers showing the automatically detected hemorrhages and the location of the center of the optic nerve head (ONH; marked on ImageJ) were then analyzed using the Optos “lesion detection” tool to quantify the hemorrhage frequency, total and average hemorrhage area, and average lesion distance from the optic nerve head (ONH). Hemorrhage frequency, total surface area (mm2), and distance from the ONH (mm) were compared between eyes that progressed to PDR over the next 2 years and those that did not, in order to define which features were associated with risk. Odds ratios for each parameter were computed following regression analysis

Results : Of the 104 eyes, 13 were excluded (2 had no DR, 11 had PDR) at baseline. Of the remaining 91 eyes, the automated software could not detect the lesions in 5 eyes due to image quality. Among the final study cohort of 86 eyes, 30 progressed to PDR. The mean (range ± standard deviation, SD) of the study parameters are shown in Table 1. Univariate regression analysis revealed that a greater distance of retinal hemorrhages from the ONH was significantly associated with a higher risk of progression (odds ratio, OR = 1.37; 95% confidence intervals, CI = 1.00-1.88; p = 0.05, whereas the hemorrhage count, and total surface area of hemorrhages did not reach statistical significance (Table 2)

Conclusions : A greater distance from the ONH of automatically detected hemorrhages on UWF imaging appears to be predictive of progression to PDR, highlighting the importance of more peripheral retinopathy in the risk stratification of DR patients. Future studies including automatic detection of other DR features, may further enhance the predictive model

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Descriptive analysis

Descriptive analysis

 

Regression analysis

Regression analysis

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×